tbuckley/cabot-search huggingface dataset:
Coronary Atherosclerosis Phenotypes in Focal and Diffuse Disease
Authors: Koshiro Sakai, Takuya Mizukami, Jonathon Leipsic, Marta Belmonte, Jeroen Sonck, Bjarne L. Nørgaard, Hiromasa Otake, Brian Ko, Bon-kwon Koo, Michael Maeng, Jesper Møller Jensen, Dimitri Buytaert, Daniel Munhoz, Daniele Andreini, Hirofumi Ohashi, Toshiro Shinke, Charles A. Taylor, Emanuele Barbato, Nils P. Johnson, Bernard De Bruyne, Carlos Collet
Journal: JACC. Cardiovascular imaging (2023)

The interplay between coronary hemodynamics and plaque characteristics remains poorly understood.The aim of this study was to compare atherosclerotic plaque phenotypes between focal and diffuse coronary artery disease (CAD) defined by coronary hemodynamics.This multicenter, prospective, single-arm study was conducted in 5 countries. Patients with functionally significant lesions based on an invasive fractional flow reserve ≤0.80 were included. Plaque analysis was performed by using coronary computed tomography angiography and optical coherence tomography. CAD patterns were assessed using motorized fractional flow reserve pullbacks and quantified by pullback pressure gradient (PPG). Focal and diffuse CAD was defined according to the median PPG value.A total of 117 patients (120 vessels) were included. The median PPG was 0.66 (IQR: 0.54-0.75). According to coronary computed tomography angiography analysis, plaque burden was higher in patients with focal CAD (87% ± 8% focal vs 82% ± 10% diffuse; P = 0.003). Calcifications were significantly more prevalent in patients with diffuse CAD (Agatston score per vessel: 51 [IQR: 11-204] focal vs 158 [IQR: 52-341] diffuse; P = 0.024). According to optical coherence tomography analysis, patients with focal CAD had a significantly higher prevalence of circumferential lipid-rich plaque (37% focal vs 4% diffuse; P = 0.001) and thin-cap fibroatheroma (TCFA) (47% focal vs 10% diffuse; P = 0.002). Focal disease defined by PPG predicted the presence of TCFA with an area under the curve of 0.73 (95% CI: 0.58-0.87).Atherosclerotic plaque phenotypes associate with intracoronary hemodynamics. Focal CAD had a higher plaque burden and was predominantly lipid-rich with a high prevalence of TCFA, whereas calcifications were more prevalent in diffuse CAD. (Precise Percutaneous Coronary Intervention Plan [P3]; NCT03782688).
Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction
Authors: Ravi B. Patel, Vivek Y. Reddy, Jan Komtebedde, Stephan W. Wegerich, Jadranka Sekaric, Vijay Swarup, Antony Walton, Gabriel Laurent, Stanley Chetcuti, Matthias Rademann, Martin Bergmann, Scott McKenzie, Heiko Bugger, Raphael Romano Bruno, Howard C. Herrmann, Ajith Nair, Deepak K. Gupta, Scott Lim, Samir Kapadia, Robert Gordon, Marc Vanderheyden, Thomas Noel, Steven Bailey, Zachary M. Gertz, Jean-Noël Trochu, Donald E. Cutlip, Martin B. Leon, Scott D. Solomon, Dirk J. van Veldhuisen, Angelo Auricchio, Sanjiv J. Shah
Journal: JACC Heart Failure (2023)
<i>Notes from the Field:</i> Autism Spectrum Disorder Among Children with Laboratory Evidence of Prenatal Zika Virus Exposure — Puerto Rico, 2023
Authors: Nicole M. Roth, Camille Delgado-López, Lisa D. Wiggins, Nancy Nieves Muñoz, Sarah B. Mulkey, Leishla Nieves-Ferrer, Kate R. Woodworth, Glorimar Meléndez Rosario, Mariam Marcano Huertas, Cynthia A. Moore, Van T. Tong, Suzanne M. Gilboa, Miguel Valencia-Prado
Journal: MMWR Morbidity and Mortality Weekly Report (2023)

NAAT = nucleic acid amplification test; USZPIR = U.S. Zika Pregnancy and Infant Registry.* ASD diagnosis by Diagnostic and Statistical Manual for
Arthritis Among Children and Adolescents Aged &lt;18 Years — United States, 2017–2021
Authors: Tyler D. Lites, Anika L. Foster, Michael A. Boring, Elizabeth A. Fallon, Erica L. Odom, Puja Seth
Journal: MMWR Morbidity and Mortality Weekly Report (2023)

Arthritis affects persons of all ages, including younger adults, adolescents, and children; however, recent arthritis prevalence estimates among children and adolescents aged <18 years are not available.Previous prevalence estimates among U.S. children and adolescents aged <18 years ranged from 21 to 403 per 100,000 population depending upon the case definition used.CDC analyzed aggregated 2017-2021 National Survey of Children's Health data to estimate the national prevalence of parent-reported arthritis diagnosed among children and adolescents aged <18 years.An estimated 220,000 (95% CI = 187,000-260,000) U.S. children and adolescents aged <18 years (305 per 100,000) had diagnosed arthritis.Arthritis prevalence among non-Hispanic Black or African American children and adolescents was twice that of non-Hispanic White children and adolescents.Co-occurring conditions, including depression, anxiety, overweight, physical inactivity, and food insecurity were associated with higher prevalences of arthritis.These findings highlight that children and adolescents should be prioritized for arthritis prevention and treatments by identifying risk factors for arthritis, developing self-management interventions to improve arthritis, physical activity or weight control, and screening and linking to mental health services.Health systems and payors can take steps to ensure equitable access to therapies (e.g., physical therapies and medications).
<i>Notes from the Field:</i> An Outbreak of Shiga Toxin–Producing <i>Escherichia coli</i> O157:H7 Associated with a Farming Camp — Tennessee, 2022
Authors: Lindsey Ferraro, D. J. Irving, Jack Marr, Kelly Orejuela, Erin Murray, Mugdha Golwalkar, Lisa M. Durso, Julie Viruez, Robin Rasnic, Katie Garman, John Dunn
Journal: MMWR Morbidity and Mortality Weekly Report (2023)

On June 22, 2022, the Tennessee Department of Health (TDH) was notified of a child hospitalized with Shiga toxinproducing Escherichia coli (STEC) O157:H7 after attending a farming camp at farm A. Three days later, TDH was notified of a second hospitalized child with hemolytic uremic syndrome, whose brother had attended the same camp, prompting an investigation.During the summer, farm A held three week-long summer camps teaching animal husbandry to children aged 6-10 years by assigning campers a baby goat (kid) to care for.STEC resides in the gastrointestinal tract of ruminants such as cattle, goats, sheep, and deer without causing illness in the animal* (1).Outbreaks among humans associated with petting zoos are well documented (2-5).
Soft Tick Relapsing Fever — United States, 2012–2021
Authors: Amy M. Beeson, Anne Kjemtrup, Hanna Oltean, Hannah Schnitzler, Heather Venkat, Irene Ruberto, Natalie Marzec, Devon Cozart, Leslie Tengelsen, Stephen Ladd-Wilson, Hannah Rettler, Bonny Mayes, Kelly Broussard, Ali Garcia, Lisa L. Drake, Elizabeth A. Dietrich, Jeannine Petersen, Alison F. Hinckley, Kiersten J. Kugeler, Grace E. Marx
Journal: MMWR Morbidity and Mortality Weekly Report (2023)

Soft tick relapsing fever (STRF) (also known as tickborne relapsing fever) is a rare infection caused by certain Borrelia spirochetes and transmitted to humans by soft-bodied Ornithodoros ticks. In the United States, acquisition of STRF is commonly associated with exposure to rustic cabins, camping, and caves. Antibiotic treatment is highly effective for STRF, but without timely treatment, STRF can result in severe complications, including death. No nationally standardized case definition for STRF exists; however, the disease is reportable in 12 states. This report summarizes demographic and clinical information for STRF cases reported during 2012-2021 from states where STRF is reportable. During this period, 251 cases were identified in 11 states. The median annual case count was 24. Most patients with STRF (55%) were hospitalized; no fatalities were reported. The geographic distribution and seasonal pattern of STRF have remained relatively constant since the 1990s. Persons should avoid rodent-infested structures and rodent habitats, such as caves, in areas where STRF is endemic. STRF surveillance, prevention, and control efforts would benefit from a standardized case definition and increased awareness of the disease among the public and clinicians.
Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus — World Health Organization African Region, 2016–2021
Authors: Hyacinte J. Kabore, Xi Li, Mary M. Alleman, Casimir M. Manzengo, Mutale Mumba, Joseph Biey, Gilson Paluku, Ado M. Bwaka, Benido Impouma, Rania A. Tohme
Journal: MMWR Morbidity and Mortality Weekly Report (2023)

Chronic hepatitis B virus (HBV) infection is one of the leading causes of cirrhosis and liver cancer. In 2019, approximately 1.5 million persons newly acquired chronic HBV infection; among these, 990,000 (66%) were in the World Health Organization (WHO) African Region (AFR). Most chronic HBV infections are acquired through mother-to-child transmission (MTCT) or during early childhood, and approximately two thirds of these infections occur in AFR. In 2016, the World Health Assembly endorsed the goal of elimination of mother-to-child transmission (EMTCT) of HBV, documented by ≥90% coverage with both a timely hepatitis B vaccine (HepB) birth dose (HepB-BD) and 3 infant doses of HepB (HepB3), and ≤0.1% hepatitis B surface antigen (HBsAg) seroprevalence among children aged ≤5 years. In 2016, the WHO African Regional Committee endorsed targets for a 30% reduction in incidence (≤2% HBsAg seroprevalence in children aged ≤5 years) and ≥90% HepB3 coverage by 2020. By 2021, all 47 countries in the region provided HepB3 to infants beginning at age 6 weeks, and 14 countries (30%) provided HepB-BD. By December 2021, 16 (34%) countries achieved ≥90% HepB3 coverage, and only two (4%) achieved ≥90% timely HepB-BD coverage. Eight countries (17%) conducted nationwide serosurveys among children born after the introduction of HepB to assess HBsAg seroprevalence: six countries had achieved ≤2% seroprevalence, but none had achieved ≤0.1% seroprevalence among children. The development of immunization recovery plans following the COVID-19 pandemic provides an opportunity to accelerate progress toward hepatitis B control and EMTCT, including introducing HepB-BD and increasing coverage with timely HepB-BD and HepB3 vaccination. Representative HBsAg serosurveys among children and a regional verification body for EMTCT of HBV will be needed to monitor progress.
Glomerular hyperfiltration: a new marker of fibrosis severity in non-cirrhotic non-alcoholic fatty liver disease
Authors: Andrea Dalbeni, Marta Garbin, Mirko Zoncapè, Sara Sara Romeo, Filippo Cattazzo, Anna Anna Mantovani, Annalisa Cespiati, Alessandro Mantovani, Anna Ludovica Fracanzani, Emmanuel Tsochatzis, David Sacerdoti, Rosa Lombardi
Journal: Journal of Hepatology (2023)
Balancing efficacy and tolerability of first-line systemic therapies for advanced hepatocellular carcinoma: a network metanalysis
Authors: Ciro Celsa, Giuseppe Cabibbo, Gabriele Di Maria, Marco Vaccaro, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Roberta Ciccia, Alessandro Grova, Mauro Salvato, Paolo Giuffrida, Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Michela Antonucci, Piera Morana, Marco Enea, Calogero Camma
Journal: Journal of Hepatology (2023)
Role of GATA4 in the modulation of hepatic progenitor cell fate
Authors: Laura Villamayor, Noelia Arroyo, Silvia Calero, Pedro Miguel Rodrigues, Elena Carceller-Lopez, Malgorzata Milkiewicz, Piotr Milkiewicz, Jesus Maria Banales, Anabel Rojas, Angela Martinez Valverde
Journal: Journal of Hepatology (2023)
Liver Frailty Index is associated with progression-free survival in patients with advanced HCC treated with Atezolizumab/Bevacizumab
Authors: Philippe Sultanik, Edouard Larrey, Manon Evain, Bertille Campion, Amandine Ait Oufella, Héloise Giudicelli, Mathilde Wagner, Dominique Thabut, Manon Allaire
Journal: Journal of Hepatology (2023)
The ALBI grade refines prognostic prediction in advanced hepatocellular cancer and enables risk stratification for bleeding events following atezolizumab plus bevacizumab
Authors: Antonio D’Alessio, Claudia Fulgenzi, Bernhard Scheiner, James Korolewicz, Jaekyung Cheon, Naoshi Nishida, Celina Ang, Thomas Marron, Linda Wu, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Matthias Pinter, Lorenz Balcar, Yi-Hsiang Huang, Aman Mehan, Samuel Phen, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Adel Samson, Peter Galle, Masatoshi Kudo, Alessio Cortellini, Amit Singal, Lorenza Rimassa, Rohini Sharma, Hong Jae Chon, David J. Pinato
Journal: Journal of Hepatology (2023)
Development of a novel non-invasive test for prediction of liver fibrosis in patients with clinically severe obesity defined by a BMI over 50 kg/m²
Authors: Maximilian Joseph Brol, Uta Drebber, Xiaojie Yu, Robert Schierwagen, Sabine Klein, Andreas Plamper, Margarete Odenthal, Wenyi Gu, Frank Erhard Uschner, Karl-Peter Rheinwalt, Jonel Trebicka
Journal: Journal of Hepatology (2023)
Spontaneous portosystemic shunts (SPSS) regress after transjugular intrahepatic portosystemic shunt (TIPS) implantation
Authors: Theresa Bucsics, Katharina Lampichler, Maria Schoder, Lukas Reider, Konstantin Vierziger, Lukas Hartl, David Jm Bauer, Mathias Jachs, Georg Semmler, Rafael Paternostro, Philipp Schwabl, Lorenz Balcar, Katharina Pomej, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
Journal: Journal of Hepatology (2023)
Growth differentiation factor 15 in plasma and liver is associated with hepatic oxidative stress in non-alcoholic fatty liver disease
Authors: Mikkel Werge, Josephine Grandt, Mira Thing, Liv Hetland, Elias Rashu, Anne-Sofie Houlberg Jensen, Anders Junker, Martin Richter, Søren Møller, Flemming Bendtsen, Lea Mørch Harder, Gianluca Mazzoni, Birgitte Viuff, Henning Hvid, Sebastian Jørgensen, Kristian Bendtsen, Jonas Kildegaard, Mogens Vyberg, Reza Serizawa, Elisabeth Galsgaard, Nicolai J Wewer Albrechtsen, Lise Lotte Gluud
Journal: Journal of Hepatology (2023)
Dynamics of liver stiffness measurements provide incremental prognostic information in advanced chronic liver disease
Authors: David JM Bauer, Zhenwei Yang, Fiona Köck, Laurenz Fritz, Benedikt Hofer, Lorenz Balcar, Lukas Hartl, Mathias Jachs, Katharina Stopfer, Theresa Bucsics, Benedikt Simbrunner, Bernhard Scheiner, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Georg Semmler
Journal: Journal of Hepatology (2023)
Bacterial exosomes cargo vaccine with EpCAM aptamers for targeting hepatocellular carcinoma
Authors: Pushpa Yadav, Babu E Preedia, Nuno Viegas, Anupama Parasar, Riddhi Sharma, Gayatri Ramakrishna, Nirupma Trehanpati, Shiv Kumar Sarin
Journal: Journal of Hepatology (2023)
Characterisation of invariant natural killer T cells in human hepatic biopsies
Authors: Elena Jiménez-Martí, Maria Aguilar Ballester, Gema Hurtado-Genovés, Luis Sabater Ortí, Marina Garcés Albir, Dimitri Dorcaratto, Sergio Martínez-Hervás, Herminia González-Navarro
Journal: Journal of Hepatology (2023)
Dickkopf-1 inhibitor enhances the anti-tumor effects of sorafenib through inhibition of PI3K/Akt/Wnt signaling in hepatocellular carcinoma
Authors: Sang Hyun Seo, Kyung Joo Cho, Hye Jung Park, Hye Mi Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal: Journal of Hepatology (2023)
What is the most effective strategy to identify HBV-infected pregnant women eligible for antiviral prophylaxis in Burkina Faso? A modelling study on different testing strategies
Authors: Andréa Gosset, Yusuke Shimakawa, Alice N. Guingané, Abdoul Tiendrebeogo, Maria Patrizia Carrieri, Tim Hallett, Shevanthi Nayagam, Sylvie Boyer
Journal: Journal of Hepatology (2023)
Incidence of hemochromatosis in HFE p.H63D homozygote and p.C282Y/H63D compound heterozygote individuals
Authors: Lorenz Michael Pammer, Benedikt Schaefer, Bernhard Pfeifer, Sabrina Neururer, Claudia Lamina, Florian Kronenberg, Herbert Tilg, Heinz Zoller
Journal: Journal of Hepatology (2023)
Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy
Authors: Wah Loong Chan, Shi-En Chong, Felicia Chang, Kee Huat Chuah, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Wah-Kheong Chan
Journal: Journal of Hepatology (2023)
Myeloproliferative neoplasms and splanchnic vein thrombosis: results of a long-term UK prospective cohort study
Authors: Rupen Hargreaves, Anicee Danaee, David Patch, Salil Karkhanis, Israa Kaddam, Jin Un Kim, Hayder Hussein, Frederick Chen, Dominic Yu, Mallika Sekhar, Dhiraj Tripathi
Journal: Journal of Hepatology (2023)
Establishment and validation of a diagnostic model for liver inflammation in chronic hepatitis B (CHB) patients concurrent with non-alcoholic fatty liver disease (NAFLD) based on machine learning (ML)
Authors: Jie Li, Qi Xue, Fajuan Rui, Xiaorong Tian, Yayun Xu, Qi Zheng, Qing-Lei Zeng, Zebao He, Jian Wang, Weimao Ding, Chuanwu Zhu, Yuanwang Qiu, Yunliang Chen, Junqing Fan, Junping Shi, Chao Wu
Journal: Journal of Hepatology (2023)
Budesonide is associated with less weight gain than Prednisolone amongst patients with autoimmune hepatitis: results from long term follow-up in routine clinical care
Authors: Josh Orpen-Palmer, Thea Rodig, Alexander Grayston, Shannon Devlin, Michael Johnston, Jude Morris, Shouren Datta, Helen Cairns, Ewan Forrest, Stephen Barclay
Journal: Journal of Hepatology (2023)
Prognostic value of simple non-invasive tests for the risk stratification of HCC development in patients with cirrhosis due to non-alcoholic fatty liver disease
Authors: Amina Abdulle, Angelo Armandi, Gian Paolo Caviglia, Chiara Rosso, Daphne D’Amato, Gabriele Castelnuovo, Nuria Pérez Diaz del Campo, Kamela Gjini, Irene Poggiolini, Marta Guariglia, Giorgio Maria Saracco, Elisabetta Bugianesi
Journal: Journal of Hepatology (2023)
The anti-HIV drug Rilpivirine downregulates migration and proliferation of activated hepatic stellate cells: relevance for the purpose of drug repurposing in liver fibrosis
Authors: Ana Benedicto, Isabel Fuster-Martínez, Aleksandra Gruevska, Eduardo Carbonell, Alessandra Caligiuri, Fabio Marra, Elena Muñoz, Dimitri Dorcaratto, Juan V. Esplugues, Ana Blas-García, Nadezda Apostolova
Journal: Journal of Hepatology (2023)
Dual alpha-v/beta-6 and alpha-v/beta-1 integrin inhibitor bexotegrast attenuates profibrogenic gene expression of myofibroblasts in human liver explant tissue with biliary fibrosis
Authors: Steve Ho, Chris Her, Richard Ahn, Vikram Rao, Jessie Lau, Mahru An, Scott Turner, Martin Decaris, Johanna Schaub
Journal: Journal of Hepatology (2023)
Effects of a one-month consumption of different non-alcoholic beers on metabolic and liver health in young men
Authors: Henriette Kreimeyer, Svenja Sydor, Lara Kaiser, Cagatay Toskal, Anja Figge, Jan Best, Josef Pospiech, Oliver Götze, Jan-Peter Sowa, Mustafa Özcürümez, Ali Canbay, Lars Bechmann, Paul Manka
Journal: Journal of Hepatology (2023)
Metabolic rewiring by increased mitochondrial respiration drives immunosuppression in liver cancer
Authors: Naroa Goikoetxea, Leire Egia-Mendikute, Miren Bravo, Marina Serrano-Macia, Teresa Cardoso Delgado, Iraia Ladero, Elena Molina, Sofia Lachiondo-Ortega, Rubén Rodríguez Agudo, Janire Castelo, Diego Barriales, Begoña Rodriguez Iruretagoyena, Eva Santamaria, Maria Mercado-Gómez, Irene González-Recio, Mercedes Rincón, Matías A Avila, Juan Anguita, Natalia Elguezabal, Asís Palazón, María Luz Martínez-Chantar
Journal: Journal of Hepatology (2023)
Long-term outcome following liver transplantation for chronic liver disease in intensive care unit: the French nationwide experience
Authors: Magdalena Meszaros, Faouzi Saliba, Claire Francoz, Christophe Duvoux, Filomena Conti, François Faitot, Pauline Houssel-Debry, Jean Hardwigsen, Marie-Noëlle Hilleret, Claire Vanlemmens, Ephrem Salamé, Nassim Kamar, Jean Gugenheim, Armand Abergel, Claire Perignon, Laurence Chiche, Maryline Debette Gratien, Jean-Yves Mabrut, Sebastien Dharancy, Jérôme Dumortier, Georges-Philippe Pageaux, Florent Artru
Journal: Journal of Hepatology (2023)
b-Klotho deficiency in hepatic stellate cells (HSCs) prompts inflammation, oxidative stress and a pro-fibrotic phenotype
Authors: Giada Tria, Erika Paolini, Miriam Longo, Nadia Panera, Roberto Piciotti, Anna Alisi, Marica Meroni, Paola Dongiovanni
Journal: Journal of Hepatology (2023)
NLRP3 and IL-1, but not IL-18, are drivers of hepatocellular carcinoma in two independent murine models
Authors: Mona Peltzer, Antje Mohs, Jan G. Hengstler, Serena Pelusi, Luca Valenti, Carolin V. Schneider, Kai Markus Schneider, Christian Trautwein
Journal: Journal of Hepatology (2023)
Impact of PNPLA3 rs738409 single nucleotide polymorphism and carbohydrate intake for the personalized management of patients with non-alcoholic fatty liver disease
Authors: Nuria Pérez Diaz del Campo, Eleonora Dileo, Gabriele Castelnuovo, Chiara Rosso, Gian Paolo Caviglia, Daphne D’Amato, Amina Abdulle, Marta Guariglia, Angelo Armandi, Kamela Gjini, Irene Poggiolini, Antonella Olivero, Maria Lorena Abate, Giorgio Maria Saracco, Elisabetta Bugianesi
Journal: Journal of Hepatology (2023)
Graft steatosis and donor diabetes mellitus additively increase the risk of retransplantation and death in adult liver transplantation -data from the Eurotransplant registry
Authors: Milan Sonneveld, Fatemeh Parouei, Caroline den Hoed, Jeroen de Jonge, Morteza Salarzaei, Robert Porte, Harry LA Janssen, Marieke van Rosmalen, Serge Vogelaar, Adriaan Van der Meer, Raoel Maan, Sarwa Darwish Murad, Wojciech Polak, Willem Pieter Brouwer
Journal: Journal of Hepatology (2023)
Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression
Authors: Romina Salpini, Lorenzo Piermatteo, Stefano D’Anna, Leonardo Duca, Giulia Torre, Anna Francesca Guerra, Chiara Boarini, Alessandro Tavelli, Paolo Ventura, Francesca Ceccherini Silberstein, Antonello Pietrangelo, Massimo Puoti, Antonella d’Arminio Monforte, Gianluca Abbati, Upkar Gill, Patrick Kennedy, Valentina Svicher
Journal: Journal of Hepatology (2023)
Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation
Authors: Haoming Zhou, Yu Sun, Haoran Hu, Jian Xu, Yiyun Gao, Xinyu Zhan, Shun Zhou, Weizhe Zhong, Dongming Wu, Ping Wang, Lianbao Kong, Zhuqing Rao
Journal: Journal of Hepatology (2023)
Lifestyle-related population-attributable risk for non-alcoholic fatty liver disease in adolescents and youth
Authors: Vanessa Garcia-Larsen, Hani Tamim, Saad Alghamdi, Mohammad Ali Shagrani, Faisal Abaalkhail, Walled AlhamoudiI, Faisal Sanai, Saleh Alqahtani
Journal: Journal of Hepatology (2023)
Deep learning-based model in pre-operative computed tomography for prediction of hepatocellular carcinoma recurrence after curative surgery
Authors: Rex Wan-Hin Hui, Keith Wan Hang Chiu, I-Cheng Lee, Chenlu Wang, Ho Ming Cheng, Lok-Ka Lam, Lung Yi Loey Mak, Nam-Hung Chia, Chin-Cheung Cheung, Yi-Hsiang Huang, Man-Fung Yuen, Philip Yu, Wai-Kay Seto
Journal: Journal of Hepatology (2023)
Head-to-head comparison of Agile 3+, LSM-VCTE, NFS, and FIB-4 scores for detecting advanced fibrosis in patients with type 2 diabetes seen in diabetes clinic
Authors: Laurent Castéra, Tiphaine Vidal-Trecan, Tania Khoury, Jean-Baptiste Julla, Valérie Paradis, Jean-Pierre Riveline, Dominique Valla, Jean-François Gautier
Journal: Journal of Hepatology (2023)
PD-L1 small molecule inhibitors and Paclitaxel orchestrating CD8+ cell cytotoxicity via tumor-associated macrophages: a personalized HCC immunotherapeutic approach
Authors: Israa Helal, Monica A. Kamal, Ahmed Ramadan, Tamer Elbaz, Mohamed Mahmoud Nabeel, Sally Elfishawi, Hend Ibrahim Shousha, Ashraf Omar, Yasmine M. Mandour, Hend El Tayebi
Journal: Journal of Hepatology (2023)